Assets Endring Dato
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amarin USD 839.03M 20.99M 2023-09
Amgen USD 97.15B 6.62B 2023-12
Baxter International USD 28.28B 2.38B 2023-12
Cara Therapeutics USD 115.34M 19.05M 2023-09
Cytokinetics USD 824.32M 83.7M 2023-12
Eli Lilly USD 57.92B 3.1B 2023-09
Esperion Therapeutics USD 221.3M 13.32M 2023-09
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Intra Cellular Therapies USD 728.3M 10.63M 2023-12
Intrexon USD 190.69M 16.84M 2023-09
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
MannKind USD 475.2M 154.87M 2023-12
Minerva Neurosciences USD 63.13M 4.01M 2023-09
Nektar Therapeutics USD 442.24M 52.04M 2023-09
Peregrine Pharmaceuticals USD 454.64M 12.3M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Rigel Pharmaceuticals USD 115.32M 1.77M 2023-09
United Therapeutics USD 7.17B 143.4M 2023-12
Vanda Pharmaceuticals USD 641.68M 2.85M 2023-06



Halozyme Therapeutics Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.